CLINICAL_TRIALS trial_result · 2012-04-13

Clinical Trial Update: Acute Myeloid Leukaemia (AML) Patients Undergoing Induction Chemotherapy [Phase 2]

Phase 2 clinical trial update for Acute Myeloid Leukemia patients undergoing induction chemotherapy, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Toronto Rehabilitation Institute | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2012-04-13